Taken together, these data suggest that Nrf2 deficiency exacerbates inflammation in NASH livers by promoting Hippo signaling in a ROS-dependent manner, which in turn regulates NLRP3 activation in a YAP /β-catenin/XBP1-dependent manner. The gene discussed is NFE2L2; the disease is metabolic dysfunction-associated steatohepatitis.